Growth differentiation factor 15 (GDF-15) polypeptides
US10336798B2 · kind B2 · utility
9Cited by
9References
21Claims
0Family size
Inventors
Key dates
| Filing date | Jun 16, 2017 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Jun 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
GDF15 polypeptides, constructs comprising GDF15, and mutants thereof are provided. In various embodiments the GDF15 polypeptides, constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.